跳至主要内容
临床试验/NCT00397475
NCT00397475已完成不适用

Evaluation of Colecalciferol Substitution in Dialysis Patients

University Hospital, Saarland1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2006年11月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
CD14/CD16-Monocyte-Subsets (Frequency)

研究概览

简要总结

The purpose of this study is to determine the effect of a colecalciferol substitution in dialysis patients on bone metabolism and immune system

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Serum 25-OH-Vit.D-levels < 60 ng/ml
  • •Age > 18 years
  • •dialysis treatment > 3 Months
  • •signed written informed consent
  • •Serum-Calcium-levels < 2,6 mmol/l within the last 4 weeks
  • •Serum-Phosphate-levels < 7,0 mg/dl within the last 4 weeks
  • •Ca x P-Product < 75 mg2/dl2 within the last 4 weeks

排除标准

  • •Serum 25-OH-Vit.-D-levels > 60 ng/ml
  • •concommitant participation in another interventional trial
  • •psychiatric disorders preventing from valid informed consent
  • •Hyperphosphatemia (> 7,0 mg/dl) within the last 4 weeks
  • •Hypercalcemia (> 2,6 mmol/l) within the last 4 weeks
  • •Ca x P-Product > 75 mg2/dl2 within the last 4 weeks
  • •pregnancy or lactation
  • •known malignancy
  • •liver disease, defined as 2-fold upper limit of ASAT-, or ALAT-levels
  • •PTH levels < 50 pg/ml
  • •current clinically relevant infections treated with antibiotic therapy and raised hsCRP levels
  • •Chronic viral Infectious diseases (e.g. HIV, Hepatitis B or C)
  • •Immunosuppressant Medication
  • •known hematologic disorders, other than renal anemia
  • •age below 18 years
  • •known anaphylactic reaction against the study medication or other ingredients of the study drug preparation
  • •renal calculus
  • •Pseudohypoparathyroidism
  • •Medication including cardiac glycosides
  • •Sarkoidosis

结局指标

主要结局

CD14/CD16-Monocyte-Subsets (Frequency)

次要结局

  • Production of Cytokines: IFN-γ, TNF-α
  • Serum levels of Calcium, Phosphorus, iPTH, hsCRP, alkaline phosphatase
  • Th1/Th2- and Tc1/Tc2-Lymphocyte-Frequency

研究者

发起方
University Hospital, Saarland
申办方类型
Other

研究点 (1)

Loading locations...

相似试验